Literature DB >> 23485725

Enhanced anti-cancer activity of human dendritic cells sensitized with gamma-irradiation-induced apoptotic colon cancer cells.

Sun Kyung Kim1, Cheol-Heui Yun, Seung Hyun Han.   

Abstract

Properly sensitized dendritic cells (DCs) can be an effective immunotherapeutic against cancers. We investigated the phenotypic and functional changes in human DCs sensitized with γ-irradiated colon cancer cell-line HT-29 (GIH). GIH induced maturation and activation of DCs. GIH-sensitized DCs showed increased cytotoxic activity against HT-29 through higher expression of perforin and granzyme B. They further induced expression of effector cytokines, cytotoxic molecules, and mucosal-homing receptor in autologous T-cells. Conclusively, these results suggest that effective anti-cancer activity is induced when DCs are sensitized with γ-irradiated cancer cells via both direct augmentation of the cytotoxicity and indirect activation of T cells.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23485725     DOI: 10.1016/j.canlet.2013.02.038

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Induction of Dendritic Cell Maturation and Activation by a Potential Adjuvant, 2-Hydroxypropyl-β-Cyclodextrin.

Authors:  Sun Kyung Kim; Cheol-Heui Yun; Seung Hyun Han
Journal:  Front Immunol       Date:  2016-10-20       Impact factor: 7.561

2.  Killed Whole-Cell Oral Cholera Vaccine Induces CCL20 Secretion by Human Intestinal Epithelial Cells in the Presence of the Short-Chain Fatty Acid, Butyrate.

Authors:  Ju-Ri Sim; Seok-Seong Kang; Daesang Lee; Cheol-Heui Yun; Seung Hyun Han
Journal:  Front Immunol       Date:  2018-01-29       Impact factor: 7.561

Review 3.  Modulating Both Tumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness.

Authors:  Qiuji Wu; Awatef Allouch; Isabelle Martins; Catherine Brenner; Nazanine Modjtahedi; Eric Deutsch; Jean-Luc Perfettini
Journal:  Front Immunol       Date:  2017-05-26       Impact factor: 7.561

4.  Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathway-mediated Killer Activity.

Authors:  Terutsugu Koya; Ryu Yanagisawa; Yumiko Higuchi; Kenji Sano; Shigetaka Shimodaira
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

5.  Serine-Rich Repeat Adhesins Contribute to Streptococcus gordonii-Induced Maturation of Human Dendritic Cells.

Authors:  Eun Byeol Ko; Sun Kyung Kim; Ho Seong Seo; Cheol-Heui Yun; Seung Hyun Han
Journal:  Front Microbiol       Date:  2017-03-31       Impact factor: 5.640

6.  Combination Treatment of Stereotactic Body Radiation Therapy and Immature Dendritic Cell Vaccination for Augmentation of Local and Systemic Effects.

Authors:  Chul Won Choi; Min Ho Jeong; You-Soo Park; Cheol-Hun Son; Hong-Rae Lee; Eun-Kyoung Koh
Journal:  Cancer Res Treat       Date:  2018-06-06       Impact factor: 4.679

7.  Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.

Authors:  Oleg V Markov; Nadezhda L Mironova; Sergey V Sennikov; Valentin V Vlassov; Marina A Zenkova
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

Review 8.  Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity.

Authors:  Aleksandra M Dudek; Shaun Martin; Abhishek D Garg; Patrizia Agostinis
Journal:  Front Immunol       Date:  2013-12-11       Impact factor: 7.561

9.  Cancer stem cells as targets for DC-based immunotherapy of colorectal cancer.

Authors:  Magdalena Szaryńska; Agata Olejniczak; Jarosław Kobiela; Dariusz Łaski; Zbigniew Śledziński; Zbigniew Kmieć
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

Review 10.  Tumoricidal activity of human dendritic cells.

Authors:  Jurjen Tel; Sébastien Anguille; Claire E J Waterborg; Evelien L Smits; Carl G Figdor; I Jolanda M de Vries
Journal:  Trends Immunol       Date:  2013-11-18       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.